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Summary 
The functional necessity for two CD28 counterrecep 
ton, (87-l and 87-2) is presently unknown. 87-l and 
87-2 equivalently costimulate IL-2 and interferon-y 
(IFNy) production and IL-2 receptor a and 1 chain ex- 
pression. 87-2 Induces significantly more IL-4 produc- 
tion than 87-1, with the greatest difference seen In 
nalve T cells. Repetitive costlmulation of CD4 + CD48RA + 
T cells with 87-2 results in moderate levels of both IL-4 
and IL-2, whereas repetitive costimulation wlth 87-l 
results in high levels of IL-2 and low levels of IL-4. 
Therefore, 87-l and 87-2 costimulation mediate dls- 
tinct outcomes, since 87-2 provides an Initial signal to 
induce naive T cells to become IL-4 producers, thereby 
directing the Immune response more towards ThOl 
Th2, whereas 87-l is a more neutral differentlative 
signal. 
Introduction 
The 87 family of CD28/CTLA4 counterreceptors is com- 
posed of at least two members of the immunoglobulin su- 
pergene family, 87-l (CD80) (Freedman et al., 1987; Free- 
man et al., 1989) and B7-2 (CDS@ (Freeman et al., 1993b; 
Azuma et al., 1993), which demonstrate only modest 
amino acid conservation. In spite of their structural differ- 
ences, both 87-l and 87-2 have been shown to signal 
through CD28 and equivalently costimulate T cell prolifer- 
ation and interleukin-2 (IL-2) production (Freeman et al., 
1993b). However, 87-l and 87-2 are differentially expressed 
on populations of antigen-presenting cells (APCs). Mono- 
cytes constitutively express 87-2 (Azuma et al., 1993; No- 
zawa et al., 1993), whereas 87-l is induced after culture 
with interferon? (IFNy; Freedman et al., 1991). On B cells, 
87-2 is rapidly expressed following activation, whereas 
87-l expression appears significantly later (Boussiotis et 
al., 1993b; Freeman et al., 1993b; Hathcock et al., 1994; 
Lenschow et al., 1994). 87-2 is expressed at low levels 
on unstimulated dendritic cells and expression of both 
87-l and 87-2 is up-regulated by granulocyte-macro- 
phage colony-stimulating factor (GM-CSF) (Hart et al., 
1993; Caux et al., 1994; Hathcock et al., 1994; Larse 
al., 1994) 
Increasing evidence suggests that CD28-mediated 
stimulatory signals are important at several stages I 
cell differentiation. To initiate their first proliferative cy 
naive T cells require T cell receptor (TCR) signaling 
a second signal, which can be provided by CD28, resul 
in secretion of IL-2 (Ehlers and Smith, 1991; Sagest 
et al., 1993; McKnight et al., 1994). Following additic 
exposures to TCR and CDP&mediated signaling, IL-2 
creting T cells differentiate into ThO T cells capabll 
secreting multiple cytokines. The evolution of an imm 
response is regulated by specific cytokines present in 
microenvironment (Mosmann and Coffman, 1989). Th 
cytokines direct CD4+ T cells td differentiate into suk 
capable of secreting distinct patterns of lymphokines 
der and Paul, 1994). Increasing evidence demonstr; 
that the monokine IL-12 (Kubin et al., 1994; Murphy ei 
1994) and, to a lesser extent IFNy, direct CD4+ T c 
to differentiate into Thl cells, which secrete lymphok 
(IL-2, IFNy, tumor necrosis factor-8 [TNFB]) critical fol 
generation of a cellular immune response and, in rr 
for immunoglobulin G2a (IgGPa) antibody productior 
contrast, IL-4 priming is necessary to direct @4+ T ( 
to differentiate into Th2 cells, which secrete 11411-5, 
IL-lo, which, in mice, are critical for IgGl and IgE antit 
production and immunity against helminthic paras 
(Swain et al., 1990; Hsieh et al., 1992; Seder et al., 19 
IL-4 and IL-10 also inhibit macrophage activation and I 
gen presentation, thereby down-regulating the cellula 
mune response (Fiorentinoet al., 1991; Hsieh et al., 11 
Ding et al., 1993; Powrie et al., 1993). When both IL4 
IL-12 are added to in vitro cultures, IL4 dominates 1 
11-12, driving naive CD4’T cells toward Th2 cells (Hsk 
al., 1993); however, in vivo, administration of IL-12 inh 
Th2 development (Oswald et al., 1994). Taken togei 
these observations suggest that signaling via both C 
and specific cytokine receptors is critical to direct the 
larization of T cells toward CD4+ Th subsets. 
Several recent murine studies demonstrate tha 
CD28 pathway is critical for the development of 
producing T ceils. Using an in vivo model of helmi 
parasitic infection, Lu et 91. (1994) demonstrated 
CTLA4-lg blocked T cell IL4 production and thereby i 
ited both B cell activation and IgE secretion. Leishn 
infection of BALB/c mice results in fatal disease as 
ated with the generation of Th2 cells, which inhibi 
differentiation of protective Thl cells. In Leishm 
infected mice, early short-term blockade with CTLI 
inhibits IL4 production and protects against letha 
ease, suggesting that the priming of Th2 is deper 
upon the CD28 pathway (Corry et al., 1994). Similarly 
transgenic model of autoantibody production (of prin 
IL-4-dependent IgGl isotype), early short-term bloc 
with CTLA4-lg inhibited autoantibody production (h 
et al., 1994). These studies provide indirect, but in 
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Figure 1. Inhibition of IL-2 and IL4 mRNA Synthesis in an MLR by 
CTLAlGlg or anti-87-l or anti-B7-2 
MLR of fully mismatched allogeneic donors and recipients were under- 
taken in the presence or absence of 10 ug/ml CTLA4-lg, anti-BF1 
MAb (clone 133). and/or anti-B7-2 MAb (clone IT2.2) or isctype- 
mitched control antibodies. IL-2 and IL4 mRNA levels were deter- 
mined by quantitative RT-PCR and are expressed as attomoles of 
specific mRNA per ~1 of cDNA. The percent reduction in mRNA levels 
is indicated to the right. Error bars indicate SD. Results are the average 
of three experiments that all had similar results. Similar results were 
also observed using either of two different anti-B7-I MAbs and three 
different anti-B7-2 MAbs. 
evidence that the CD28 pathway is involved in IL4 pro- 
duction. 
These studies, in conjunction with differences in the 
structure, expression, and ligand binding of B7-1 and 87-2, 
suggested the possibility that 87-l and 87-2 might deliver 
distinct signals. The present studies were undertaken to 
address these issues directly using B7-1 and 87-2 tram+ 
fectants. Here, we demonstrate that both 87-l and 87-2 
are equivalent in their ability to induce IL-2 and IFNy pro- 
duction and interleukin-2 receptor (IL-2R) expression. 
More importantly, we demonstrate that 87-2 more effec- 
tively costimulates the production of IL-4 and appears to 
be capable of directing the differentiation of Tcells towards 
a more ThP-like phenotype. 
Results 
Blockade of Costimuiation Mediated by 87-2, but 
Not 87-1, Greatly Reduces IL-4 mRNA Synthesis 
During a Primary Ailogenelc Mixed 
Lymphocyte Reaction 
Previous work has shown that anti-B7-2 monocionai anti- 
body (MAb) blocks proliferation of a mixed leukocyte reac- 
tion (MLR) more effectively than does anti-B7-1 MAb 
(Azuma et al., 1993). We sought to determine the relative 
contributions of 87-l and 87-2 for IL-2 and IL-4 production 
in a primary MLR. Both IL-2 and IL4 mRNAs were induced 
in one-way MLR of fully mismatched allogeneic donors 
and recipients (Figure 1, media alone). IL-2 and IL4 mRNA 
levels were quantitated by competitive polymerase chain 
reaction (PCR) using PCR MIMICS as described in Experi- 
mental Procedures. The addition of anti-B7-1 MAb re- 
duced the level of IL-2 mRNA by42%, and this was statisti- 
cally significant (p < 0.05) compared with the isotype- 
matched control MAb. Anti-B7-1 MAb did not significantly 
reduce IL-4 mRNA levels compared with an isotype- 
matched control (17%; p = 0.205). In contrast, blockade 
of the MLR with anti-B7-2 MAb greatly reduced the levels 
of both IL-2 mRNA (91.78%; p < 0.005) and IL4 mRNA 
(95.88%; p < 0.005). These results confirm that 87-2 is 
the major costimulatoty molecule in an MLR. The combi- 
nation of antiB7-1 and anti-B7-2 MAbs reduced IL-2 
mRNA levels by log 3 (99.99%) and IL-4 mRNA to unde- 
tectable levels. The combination of antiB7-1 and anti-B7-2 
MAbs was consistently more effective than CTLA4-ig at 
reducing both IL-2 (p < 0.032) and IL-4 mRNA levels (p < 
0.05). The more effective blockade by anti-B7-1 plus anti- 
87-2 MAbs may be explained by the rapid on-off rate of 
CTLA4-ig binding to 87-2 (Linsley et al., 1994). 
Differential Induction of Cytokines in CD4+ 1 Cells 
by 87-l and 87-2 Costimulation 
The inhibition of IL4 mRNA synthesis by anti-B7-2 MAb 
might be a direct consequence of blocking a B7-2-medi- 
ated signal for IL-4 production or a secondary conse- 
quence of blocking IL-2 synthesis. To examine whether 
87-l and 67-2 mediate the same or different costimulatory 
signals, we prepared Chinese hamster ovary (CHO) cell 
transfectants expressing high levels of 87-l or 87-2. Im- 
munophenotyping showed very similar levels of expres- 
sion with a mean fluorescence intensity for 87-l and 87-2, 
respectively, of 32 and 28 with isotype-matched MAbs and 
173 and 79 with CTLA4-lg (Figure 2a). The P-fold differ- 
ence in CTLA4-lg binding compared with isotype-matched 
MAbs most likely reflects the higher on-off rate of CTLAC 
lg binding for 87-2 (Linsley et al., 1994). To determine 
whether costimulation mediated by 87-l and 87-2 differ- 
entially regulated the production of cytokines, we provided 
a first signal to human CD4+ T cells with anti-CD3 MAb 
and a costimulatory signal with either CHO/B7-1 or CHOl 
87-2. Protein accumulation of IL-2, IFNy, TNF8, GM-CSF, 
and IL-4 was examined by enzyme-linked immunosorbent 
assay(ELISA; Table 1). 87-l and B7-2equivalentiycostim- 
ulated production of IL-2 and IFNy. In contrast, B7-2 costim- 
ulated 3-fold higher levels of TNF8 production but one- 
half the level of GM-CSF compared with 87-l. Only 87-2 
induced expression of IL-4 protein, albeit at low levels. 
These differences were consistently observed. CTLA4-lg 
inhibited cytokine production to levels equivalent to that 
observed for anti-CD3 alone (Table 1). 
The dose-response of IL-4 production by CD4+ T cells 
in response to anti-CD3 MAb plus increasing numbers of 
CHO/B7-1 or CHO/B7-2 transfectants was examined. 
Only CHO/B7-2 induced IL4 accumulation with increasing 
production up to 20,000 CHO/B7-2 cells per 50,000 T cells 
(Figure 3). IL-4 production declined with very high numbers 
of CHO/B7-2 cells, probably because of toxicity caused 
by the high number of CHO cells as T cell proliferation 
also declined. CHO/B7-1 did not induce IL-4 production 
at any number of CHO/B7-1 cells tested (2,500-80,000). 
IL-4 and G3PDH (positive control) mRNA expression 
was examined by reverse transcriptase (RT)-PCR (Figure 
4). No IL-4 transcripts were detectable when CD4+ T cells 
were cultured in media in the absence or presence of anti- 
CD3 MAb. Anti-CD3 MAb plus CHO/B7-2 induced expres- 
sion of IL4 mRNA (Figure 4). Quantitative PCR of IL4 
mRNA using MIMICS gave an estimate of approximately 
5 x 1 Oe4 attomollul of cDNA (data not shown). Blockade 
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of 67-2 costimulation with anti-CD28 Fab reduced IL4 
mRNA levels to undetectable levels. In contrast, anti-CD3 
plus CHO/B7-1 did not result in the production of any IL-4 
mRNA detectable by PCR. 
87-S and B7-24ediated Costimulation Equivalently 
UpRegulate IL-2Ra and IL-2R1 
Chain Expression 
Since accumulation of IL-2 and expression of sufficient 
numbers of high affinity receptors are critical for T cell 
clonal expansion, we sought to determine whether costim- 
uiation mediated by B7-1 and 87-2 would induce the a 
and y chains of the IL-2R. IL-2Ra’ and IL-2Ry+ T ceils were 
first removed from CD4’ T ceil populations by MAb and 
magnetic bead depletion. IL-2Ra- IL-2Ry- CD4+ T cells 
were subsequently cultured with either anti-CD3 alone or 
anti-CD3 in the presence of CHO/B7-1 or CHO/B7-2 cells. 
Stimulation of the IL-2Ra- IL-2Ry-CD4+Tceils in the pres- 
ence of either 87-l or 87-2 resulted in significant up- 
regulation of IL-2Ra and IL-2Ry within 12 hr of culture. At 
48 hr, most T cells coexpressed IL-2Ra and IL9Ry (Figure 
5, middle and bottom). In contrast, culture of IL-2Ra- IL- 
2Ry- CD4’ T cells with anti-CD3 alone resulted in up- 
regulation of IL-2Ra and IL-2Ry only after 48 hr of culture 
and on only a minority of cells (Figure 5, top). These results 
further explain the mechanism by which CD28 costimuia- 
tion may prevent the induction of anergy by hastening 
and increasing the production of both IL-2 and the IL-2Ra 
(Cerdan et al., 1992; Reiser et al., 1992), p (Cerdan et al., 
1995), and common y chains. Induction of common y chain 
by 87-l- and B-/-e-mediated costimulation may also pro- 
Figure 2. Phenotypes of Transfectants 
(A) CHO cells transfected with the cDNP 
87-l or 87-2 or (6) NIH 3T3 cells transfc 
with the cDNAs for DR7and either 87-l or 
were stained with anti-DR MAb coupled to 
coerythrin or with isotypematched (lg 
MAbs for 87-l (4B2.C4), 87-2 (HF2.3D’ 
with CTLAQIg, or isotype-matched control 
bodies as indicated and reactivity detern 
by indirect immunofluorescence and flor 
tometry analysis. Mean fluorescence inte 
is indicated in the upper right of each pane 
COS cells transiently transfected with pCl 
vector or with cDNAs encoding DR7 and B 
87-l or 87-2 were stained with anti-DR 
coupled to phycoerythrin and CTLA4-lg 
pled to FITC and reactivity determine 
immunofluorescence and flow cytometry 
ysis. The percent cells in each quadran 
indicated. The mean fluorescence in8 
(CTLA4-Ig-FITClanti-DR-PE) of the 
transfectants was 8/5,6/125, 13/U, Ii/4 
vector, DR7, DR7/87-1, DR7/07-2, re! 
tively. 
Table 1. Differential Induction of Cytokines in CD4+ T Cells by 
and 87-2 Costimulation 
CDCT No Inhibitors +CTLAMg +aCD28 I 
IL-2 @g/ml) 
+media <18 
+aCD3 <18 
+aCD3 + CHO/B7-1 620 
+aCD3 + CHO/B7-2 840 
<16 <18 
<I8 <16 
IFN-Y (W/ml) 
+media 
+aCD3 
+aCD3 + CHO/B7-1 
+aCD3 + CHOIB7-2 
TNF B Wml) 
+media 
+aCD3 
+aCD3 + CHOIB7-1 
+aCD3 + CHOIB7-2 
GM-CSF (pg/ml) 
+media 
+aCD3 
+aCD3 + CHO/B7-1 
+aCDS + CHO/B7-2 
IL-4 @g/ml) 
+media 
+aCD3 
+aCD3 + CHOIBP1 
+aCD3 + CHO/B7-2 
<20 
<20 
320 
440 
25 
28 
123 
420 
22 
88 
400 
220 
<3 
<3 
<3 
32 
<20 32 
<20 52 
- 
22 
28 
- 
75 
26 
<3 
<3 
<3 
<3 
28 
32 
< denotes below the indicated lower limit of detection of the 
and - indicates not done. Similar results were obtained in foul 
pendent experiments. 
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Figure 3. Dose Response of IL4 Production in Response to CHO/B7-2 
CD4’ T cells (5 x IO’) were stimulated with submitogenic concentra- 
tions of anti-CD3 MAb in the presence of increasing numbers of CHOl 
97-1 or CHO/B7-2. Supernatants were harvested after 24 hr and as- 
sayed for IL4 by ELISA. 
vide one explanation for CD28 costimulation regulating 
responsiveness to IL-4 (Damle and Doyle, 1989) as the 
common y chain is shared by the 11-2, IL-4, and IL-7 recep 
tors (Russell et al., 1993). 
Differential Induction of Cytokines in a CD4+ 
Alloreactive T Cell Clone by 87-l 
and 87-2 Coitimulation 
Similar differences in lymphokine production were ob- 
served when the responding cell population was a ThO T 
cell clone, TC-3. This alioreactive T cell clone produced 
both IL-2 and IL-4 in response to a B lymphoblastoid cell 
line that coexpresses DR7 alloantigen, B7-1, and 87-2 
(Boussiotis et al., 1994a). To examine the effects of 87-l 
versus 87-2 costimulation, TC-3 cells were stimulated us- 
ing COS cells cotransfected with DR7 and either 87-l or 
87-2. Approximately 30% of the transiently transfected 
COS cells coexpressed DR7 and either 87-l or 87-2 with 
87-l being expressed at slightly higher levels (see Figure 
aCD3 
2C). Ailoantigen plus either 87-l or 87-2 equivalently co- 
stimulated IL-2 and IFNy protein production by TC-3 cells 
(Table 2). B7-2 induced a moderate level of IL4 protein 
and this level was 1 l-fold higher than that induced by 87-1, 
which was just above the lower limit of detection in this 
experiment and was below the level of detection in three 
other experiments (Table 2). 87-2 costimulation induced 
4-fold higher levels of TNF8 protein than did 87-l costimu- 
iation. 
Both 87-l and 87-2 Costimulate IL-4 Production 
in CD4+CD45RO+ T Cells but Only 87-2 
Costlmulates CD4+CD45RA+ T Cells 
to Produce IL-4 
CD4+ T cells were divided into CD45RA+ (naive) and 
CD45RO+ (memory) subsets (Morimoto and Schloss- 
man, 1993), stimulated with anti-CD3 MAb, and examined 
for the capacity of 87-l and 87-2 to costimulate cyto- 
kine production and proliferation. CHO/B7-2 costimulated 
slightly higher levels of proliferation and IL-2 production 
in CD4+CD45RA+ T cells than did CHO/B7-1. Only 87-2 
costimulated CD4+CD45RA+ T cells to secrete IL4 (Figure 
8) albeit at low levels. 87-l and B7-2 costimuiated nearly 
equivalent levels of proliferation and IL-2 production in 
CD4CD45RO’ T cells (Figure 8). Both 87-l and 87-2 co- 
stimulated IL-4 production by CD4+CD45RO+ T cells and 
87-2 consistently induced 3-fold more IL4 in CD4+CD45RO+ 
T ceils than did 87-l. Cytokine production by both 
CD4+CD45RA+ and CD4+CD45RO+ T ceils was blocked 
by CTLA4-lg. 
Repetitive Costimulatlon by 87-2 Leads to 
Increased Production of IL-4 
Since 87-l and 87-2 equivalently costimuiate IL-2 pro- 
duction, but only 87-2 costimulates IL4 production by 
CD4+CD45RA+ T cells, we sought to determine the conse- 
quences of 87-l or 87-2 costimulation on the evolution of 
IL-2 and IL4 production following repetitive stimulation 
with aiioantigen. CD4+CD45RA+ T ceils were stimulated 
with NIH 3T3 cells transfected with DR7, DR7 and 87-1, 
’ CFO B7-ll lCHO By-2 I 
bD 
Figure 4. 97-2 but Not 97-1 Costimulation In- 
duces Detectable IL4 mRNA in Unprimed 
CD4+ T Cells 
CD4’ T cells were stimulated with submito- 
genie concentrations of anti-CD3 MAb alone 
or in the presence of CHOIBF1 or CHO/B7-2 
costimulation with or without anti-CD28 Fab. 
Cells were harvested 8 hr after the initiation 
of culture, and RNA preparation and reverse 
transcription were performed as described in 
the Experimental Procedures. PCR amplifica- 
tion of 2 pg of these cDNA was performed us- 
ing oligonucleotides specific for the indicated 
genes. and equal aliquots of the reaction prod- 
ucts were electrophoresed on a 2.5% agarose 
gel containing ethidium bromide. Results are 
representative of four experiments. 
87-2 More Effectively Induces IL4 Production 
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Culture 
Conditions 
aCD3 
aCD3 
t 87-l 
aCD3 
t 87-2 
Staining 
mAb -- 
neg. 
control 
IL-2RalFIl 
IL-PRyIRD 
‘C 
neg. 
control 
IL-2Ra/FITC 
IL-ZRy/RD 
neg. 
control 
IL-2RalFITC 
IL-PRyIRD 
Log PE 
or DR7 and 87-2. The expression of DR7 with either 87-l 
or 87-2 in NIH 3T3 ceils was comparable (see Figure 28). 
T cells from each primary stimulation were restimulated 
with the identical transfectant for an additional four cycles 
and IL-2 and IL-4 accumulations were quantitated. In the 
first round of stimulation, only DR7/B7-2 transfectants in- 
duced IL4 production, albeit at low levels (Figure 7). With 
furtherroundsofstimulation, DR7/B7-2transfectantsstim- 
ulated progressively increasing levels of IL4 production 
(peak level 140 pglml), whereas DR7/B7-1 transfectants 
did not costimulate any IL4 production during the first or 
second round and low levels of IL4 were detected with 
additional rounds of stimulation (peak level 34 pglml). In 
contrast, both DR7/B7-1 transfectants and DR7/87-2 
transfectants costimulated equivalent levels of IL-2 pro- 
duction in the first and second rounds of stimulation. Stim- 
ulation with DR7/B7-1 transfectants in subsequent rounds 
resulted in increasing levels of IL-2 production (peak 2000 
Figure 5. 87-l and 87-2 Costimulatiin Rapi 
Up-Regulates IL-2Ra and IL-2Ftv Expressk 
Purified CD4+ IL-2Ra‘ IL-2Ry- T cells wt 
stimulated with submitogenic conceAtratia 
of anti-CD3 MAb alone or in the presence 
either CHO/B7-1 or CHO/B7-2. At the indical 
time intervals, cells were harvested and ( 
pression of IL-2Ra and IL-2Ry was examin 
as described in Experimental Procedures. 1 
percent cells in each quadrant are indicate 
Results are representative of three exp 
ments. 
pg/ml), whereas additional roundsof stimulation with DI 
87-2 transfectants did not lead to further increases in I 
els of IL-2 production. T ceils stimulated with DR-NB 
transfectants or DR7/B7-2 transfectants proliferated vig 
ously. In contrast, T cells stimulated with DR7 transf’ 
tants did not proliferate or produce IL-2 or IL4 and bar 
enough cells remained viable to perform the assay. Wt 
T cells were stimulated multiple rounds with either DI 
87-l transfectants or DR7/B7-2 transfectants and tr 
challenged with DR7 transfectants alone, the T cells 
not produce IL-4 (data not shown). Similar results WI 
seen in identical experiments performed with COS I 
transfectants (data not shown). These results are con! 
tent with the hypothesis that 87-2 costimulation can F 
vide a signal for production of low levels of IL4, and 1 
IL-4 is sufficient to prime for subsequent production of I 
upon restimulation but is not sufficient to drive T cell: 
terminal Th2 differentiation. 
Table 2. Differential Induction of Cytokines in a CD4+ Alloreactive T Cell Clone by 87-l and 87-2 Costimulation 
T Cell Clone (TC-3) IL-2 (pglml) IFN Y ~~9/rnl~ IL4 (Da/ml) TNF 6 (rmhl) 
+media <16 <20 <3 22 
+COS DR7iB7-1 120 220 6 96 
+COS DR7107-2 130 240 65 360 
+COS mock <16 <20 <3 16 
< denotes below the indicated lower limit of detection of the assay. Similar results were obtained in four independent experiments. 
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CD45RO 
Figure 6. Both 87-l and 87-2 Can Costimulate IL-4 Production by 
CD4+CD45RO+T Cells, but Only 87-2 Can Costimulate IL4 Production 
by CD4+CD45RA+ T Cells 
CD4+ T cells were divided into CD45RA’ and CD45RO+ subsets and 
cultured with submitogenic concentrations of anti-CD3 MAb alone or 
in the presence of CHO/B7-1 or CHO/B7-2 with or without anti-CD26 
Fab. IL-2 and IL-4 concentrations were assessed in supernatants after 
24 hr of culture and PHjthymidine incorporation was measured for the 
last 16 hr of a 72 hr culture period. Error bars indicate SD. Results 
are representative of three experiments. 
In the present report, we show that the functional out- 
comes of costimulation mediated by 87-l and 87-2 are 
different. Although 87-l and 87-2 costimulation were 
equivalent at inducing IL-2 and IFNy production and ex- 
pression of IL2-Ra and IL-2Ry chains, 87-2 more effec- 
tively costimulated IL4 and TNFj3 production, whereas 
87-l more effectively costimulated GM-CSF production. 
The most striking and functionally significant difference 
between 87-l and 87-2 was that 87-2 costimulation more 
effectively induced IL-4 production. The more effective in- 
duction of IL-4 by 87-2 costimulation has been consistently 
obsenred in different T cell populations (CD4+CD45RA+ T 
cells, CD4+CD45RO+ T cells, and an alloreactive T cell 
clone), in response to either anti-CD3 MAb or alloantigen, 
and with 87-2 expressed in either CHO, COS, or NIH 3T3 
cells. Similarly, anti-B7-2 MAb but not anti-B7-1 MAb sig- 
nificantly reduced the induction of IL-4 mRNA in a pri- 
mary human allogeneic MLR. The magnitude of the differ- 
ence in IL-4 induction by 87-l and 87-2 was dependent 
upon the differentiative state of the T cell. In unprimed 
CD4+CD45RA+ T cells (naive; Morimoto and Schloss- 
man, 1993) B7-2 induced 19-fold or more higher levels 
of IL-4 than did 87-l. In previously stimulated T cells or 
CD4+CD45RO+ T cells, 87-2 induced 3- to 11-fold more 
IL4 than did 87-l. These data support the conclusion that 
the differences between 87-2 and 87-l costimulation will 
be greatest at the initiation of an immune response and 
less pronounced thereafter. It should be emphasized that 
the levels of IL-4 induced by 87-2 costimulation are low 
and probably not sufficient to induce all of the biologic 
effects mediated by high levels of IL-4. 
Previous investigators have shown that IL4 is a domi- 
nant cytokine and IL-4 priming directs differentiation to- 
ward the Th2 subset (Swain et al., 1990; DeKruyff et al., 
1992; Hsieh et al., 1992; Seder et al., 1992; Seder and 
Paul, 1994; McKnight et al., 1994). The signals initiating 
the production of IL-4 as well as the cellular populations 
that initiate IL-4 secretion are much less well understood 
12 3 4 
Number of Stimulations 
Figure 7. Evolution of IL-2 and IL4 Production in Response to Repeti- 
tive Costimulation with 87-l or 87-2 
CD4+CD45RA+ T cells were stimulated with NIH 3T3 cells transfected 
(abbreviated t-) with DR7, DR7 and 87-1, or DR7 and 87-2. At weekly 
intervals, T cells were restimulated with the identical transfectants. 
Supernatants were harvested after each stimulation and levels of IL-2 
and IL4 were determined by ELIBA. 
(van der Pouw-Kraan et al., 1992,1993; Seder and Paul, 
1994). It has been proposed in murine systems that either 
mast cells or a subpopulation of NK cells may provide the 
initial source of IL-4 (Seder and Paul, 1994). Alternatively, 
we now show in a human in vitro system that 87-2 can 
costimulate naive T cells to produce low levels of IL-4, and 
this amount of IL-4 appears to be sufficient to prime these 
cells for further IL4 production. When CD4+CD45RA+ T 
cells were repetitively stimulated with akoantigen and 87-2, 
IL4 was induced in the first round of stimulation and in- 
creased steadily thereafter. IL-2 levels increased for the 
first two rounds but declined slightly thereafter. In contrast, 
repetitive stimulation with alloantigen and 87-l did not 
lead to any detectable IL4 production until the third round 
and low levels were produced thereafter. IL-2 production 
steadily increased with each round of 87-l costimulation 
to very high levels. Taken together, these results demon- 
strate that a major difference between the outcomes of 
87-l- and B7-2-mediated costimulation is the ability of 
87-2 to initiate and amplify IL4 secretion by naive T cells. 
Although repetitive costimulation with 87-2 led to pro- 
gressively increased, albeit low, levels of 114, IL-2 was 
still produced, demonstrating that 87-2 costimulation was 
not sufficient to drive theentire population toTh2differenti- 
ation. These results are consistent with previous studies, 
which have shown that exogenous IL4 drives T cell differ- 
entiation towards Th2 in an IL4 dose-dependent fashion 
and that low levels of exogenous IL4 lead to a mixed 
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population of T cells that secrete both IL-2 and IL-4 (Swain 
et al., 1990). Additional signals are undoubtedly required 
for higher levels of IL-4 production and terminal differentia- 
tion into Th2. A role for 87-2 in the initiation of an immune 
response by naive T cells may be to costimulate an initial 
low level of IL4 that gives T cells the option of responding 
to further differentiative signals. Since 87-2 is constitu- 
tively expressed on monocytes and dendritic cells but 87-l 
is not (Freedman et al., 1991; Azuma et al. 1993; Hart et 
al., 1993; Caux et al., 1994), the initial costimulation of an 
immune response will usually be by 87-2, perhaps ex- 
plaining why the ‘default” response of the immune system 
is towards ThO/Th2 (Hsieh et al., 1992). In contrast, B7-1 
does not induce IL-4 production in the initial rounds of 
stimulation and is thus a more neutral differentiative sig- 
nal, perhaps leaving T cells particularly sensitive to Thl 
differentiative signals such as IL-12. 
Additional recent work supports the idea that 87-l and 
87-2 are not equivalent in their in vivo biological function 
and that CD28 signaling is critical for IL-4 production. The 
antibody isotypes induced by adoptive transfer of antigen- 
pulsed APCs (De Becker et al., 1994) is consistent with 
our hypothesis that 87-2 costimulates IL-4 secretion and 
provides a moderate signal towards Th2 differentiation. 
In these studies, B7-2+, 87-V murine monocytes preferen- 
tially induced the secretion of IgGl and IgE (ThP-depen- 
dent isotypes), whereas B7-2’, 87-l+ murine dendritic 
cells induced both lgG2a and IgGl antibodies (Thl- and 
Th2-dependent isotypes). In mice, challenge with B7-l- 
transfected tumor cells leads to tumor rejection and subse- 
quent immunity against untransfected tumor cells (Chen 
et al., 1992; Baskar et al., 1993; Townsend and Allison, 
1993). These results have been replicated in a 87-l- 
transfected myeloid tumor cell line; however, the B7-2- 
transfected tumor has a much lower rate of tumor rejection 
and survivors often cannot reject untransfected tumor 
upon rechallenge (Matulonis et al., 1995; unpublished 
data). Studies of the development of T helper subsets in 
a TCR afl transgenic system have shown that splenic ad- 
herent cells stimulate the development of a mixed popula- 
tion of ThO but that the 87-l-, 87-2’ TA3 8 cell line (Free- 
man et al., 1993a) stimulates the development of Th2 
(Hsieh et al., 1992). In a murine model of experimental 
allergic encephalomyelitis (EAE), in vivo administration of 
anti-B7-1 MAb (allowing 87-2 to dominate) reduced the 
severity of disease and led to increased production of IL-4 
(Kuchroo et al., 1995). T cell clones derived from anti-B7-1 
MAb-treated mice with EAE were primarily of Th2 pheno- 
type, instead of the primarily Thl clones derived from un- 
treated animals. In contrast, in vivo administration of anti- 
67-2 MAb (allowing 87-l to dominate) increased EAE 
severity. Previous work has shown that for the generation 
of IL4-producing T cells, stimulation of uncommitted T 
cells by both IL-2 and IL4 is necessary. IL-2either provides 
a necessary signal for IL-4 production or simply a viability 
signal (Le Gros et al., 1990; Swain et al., 1990; DeKruyff 
et al., 1992; Seder et al., 1992; McKnight et al. 1994). The 
results of in vivo blocking with anti-B7-2 in the EAE model, 
therefore, could be due to direct blocking of a signal for IL4 
production or alternatively an indirect effect of blocking the 
major costimulator of IL-2 production. Our in vitro hum 
results are consistent with 87-2 providing a direct sign 
for IL4 production. Taken together, these studies suggc 
that 87-l and 87-2 are not equivalent and that CD: 
mediated signaling by 87-2 has a role in the differentiati 
of CD4+ T cells capable of secreting IL4. 
At first, it would seem surprising that 87-l and B7-2 ( 
bind to the same receptor but lead to differential induct 
of some lymphokines. However, several immunologi 
receptors have been shown to transmit signals leadins 
different outcomes depending on the ligand bound. I 
example, peptide-MHC binding to TCR normally sign 
for T cell activation but certain “altered” peptide-M 
combinations can deliver signals for T cell anergizat 
(Sloan-Lancaster et al., 1993) and these may critically 
fer in their on-off rates (Matsui et al., 1991). Linsley el 
(1994) have recently shown that 87-l and 87-2 have si 
lar low affinities for CD28 and high affinities for CTL 
but very different kinetics of binding. B7-2 binds faster 
also falls off faster than does 87-l. In addition, the bind 
determinants on CTLA4 for binding to 87-l and 87-2 di 
(Linsley et al., 1994). These differences in the binding ! 
and on-off rates may permit 87-l and 87-2 to recruit dif 
ent intracellular signaling pathways. Nunes et al. (19 
identified a number of intracellular signals induced 
cross-linking with anti-CD28 MAb but only some of tht 
were duplicated by B7-1 binding to CD28. They hypol 
sized that CD28 signals not induced by 87-l may be 
duced by 87-2. 
It is becoming increasingly apparent that subpopl 
tions of APC can direct the differentiation of a T cell 
wards Thl or Th2 by expressing distinct costimulatory 
surface proteins, secreting cytokines, or both. A crit 
question will be to understand the natural mechani: 
whereby APCs differentially express costimulatory ml 
cules in response to different pathogens and immune c 
lenges. Moreover, these observations may be clinic 
relevent in attempts to induce immunity to pathogens, 
tumors or to control autoimmunity. 
Expsrlmental Procedures 
MAba and Immunoglobulin-Fuaion Proteina 
MAbs were used as purified immunoglobulin unless indicated 01 
wise: anti-CD3 OKr3, IgGl, was from ATCC; anti-CD& 7PT 
IgGPa; antiCDllb: Mol, IgM and anti-CD14: Mo2, IgM; anti-Cl 
9.3, IgGPa (Dr. C. June, Naval Research Institute, Bethesda, hi 
land); antiCD16: 3G6, IgGl (used as ascites); anti-IL-PRY: 385, I 
(Nakarai 81 al., 1994; provided by Drs. T. Nakarai and J. Ritz, D 
Farber Cancer Institute, Boston, Massachusetts); antiCD45RA: : 
IgGl and antiCD45RO: UCHLl, IgGl (Dr. P. Beverly, University 
lege, London, and Dr. C. Morimoto, Dana-Farber Cancer lnsti 
Boston, Massachusetts); anti-87-l: 133, IgM (Freedman et al., I! 
anti-B7-2/870/CD66: IT2.2, IgGPb (Pharmingen, San Diego, Ca 
nia)and Fun-l (Nozawaet al., 1993; obtained through the Fifth Into 
tional Conference on Human Leukocyte Differentiation Antigens) 
anti-CD25 (IL-2Ra), IgGl (Coulter Corporation, Hialeah, Florida). 
CD26 Fab fragments were generated in our laboratory from the 
MAb by papain digestion and purification on a protein A column 
cording to the instructions of the manufacturer (Pierce, Rockforc 
nois). Human CTLA4-lg and control fusion protein were prepare 
previously described (Gimmi et al., 1993; f&Knight et al., 1994 
Cell Transfectlons 
CHO/B7-1 were prepared as described, and fixed with paraform, 
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hyde prior to use (Gimmi et al., 1991). CHO/B7-2 were made as de- 
scribed (Engel et al., 1994) by cotransfecting the 87-2 cDNA in the 
pCDM8 expression vector and the pPGK-Hygro vector expressing 
hygromycin resistance. Transfectants were sorted for CTLAClg bind- 
ing twice and cloned. Expression of 87-2 was confirmed by staining 
with anti-B72/870/CD86 MAbs lT2.2 (Azuma et al., 1993) and Fun-l 
(Nozawa et al., 1993). CHO/B7-2 cells were fixed with 0.4% paraform- 
aldehyde prior to use. 
NIH 3T3 cells stably transfected with DR7 (DR7 transfectants) or 
DR7 and 87-l (DR7/87-ltransfectants) have been described (Gimmi 
et al., 1993). NIH 3T3 cells stably transfected with DR7 and 87-2 (DR71 
87-2 transfectants) were prepared by cotransfecting DR7 transfectants 
cells with a 87-2 cDNA in the SRa plasmid and the pPGK-Hygro 
plasmid expressing the hygromycin-resistance gene. Transfectants 
were selected in media containing 200 &ml hygromycin and 200 us! 
ml G418. Transfectants were sorted with an anti-MHC class II MAb- 
coupled to phycoerythrin (13, Coulter Corporation, Hialeah, Florida) 
and CTLACIg coupled to fluorescein isothiocyanate (FITC). Positive 
cells were grown up, resorted and cloned. A transfected DR7/B7-2 
cloned cell line expressing equivalent amounts of MHC class II and 
CTLA4 ligand to that of the DR7/B7-1 transfectants was selected for use. 
CD4+ Human 1 Cells 
Peripheral blood mononuclear cells were isolated from healthy donors 
by density gradient centrifugation on Ficoll-Hypaque. Monocytes were 
depleted by adherence on plastic. The CD4+ T cell population was 
further enriched by separation from residual monocytes, B cells, NK 
cells and CD8+ T cells by MAb and anti-mouse immunoglobulincoated 
magnetic beads, using anti-CD1 4 (MOM), anti-CD1 1 b (Mol), anti-CD20 
(Bl), anti-CD18 (368) and anti-CD8 (7PT 3F9) MAbs. The efficiency of 
the purification was analyzed in each case by flow cytometry (Coulter, 
EPICSElite), usingantiCD3, antiCD4, antiCD8, andantiCD14MAbs 
followed by FITC-conjugated goat anti-mouse immunoglobulin (Fisher, 
Pittsburgh, Pennsylvania). The final cell preparation wasalways>99% 
CD3+, >99% CD4+, <1% CDE’, and Xl% CD14+. CD4+CD45RA+ and 
CD4CD45RO’T cell subsets, were prepared as described above, but 
with the additional use of antiCD45RO (UCHLl) for the preparation 
of the CD4+CD45RA+ cells and the addition of antiCD45RA (2H4) for 
the preparation of the CD4+CD45RO+ cells. 
T Cell Cultures 
For proliferation assays and assessment of cytokine accumulation in 
the culture supernatants, T cells were cultured at a concentration of 
5 x lO’cells/well in RPM1 1640 containing 10% heat-inactivated fetal 
calf serum, 2 mM glutamine, 1 mM sodium pyruvate. penicillin (109 
U/ml), streptomycin sulfate (100 kg/ml) and gentamycin sulfate (5 ugl 
ml) in 96well flat-bottomed microtiter plates at 37OC in 5% CO*. For 
submitogenic stimulation of unprimed CD4+T cells, anti-CD3 MAb was 
precoated onto plates at a concentration of 0.5 pg/ml for 1 hr at room 
temperature. After incubation, plates were washed with phosphate- 
buffered saline three times. CHO/B7-1 or CHO/B7-2 cells were added 
at a concentration of 2 x 10’ cells/well. Factors under study were 
added to the required concentration for a total final volume of 200 td/ 
well. Where indicated, T cells were incubated with anti-CD28 Fab (final 
concentration of 15 la/ml) for 30 min at 4OC, prior to addition in experi- 
mental plates. Cells were pulsed with 1 t&i [methyVH]thymidine (37 
kBq; Du Pont, Boston, Massachusetts)/well and incorporation during 
the last 18 hr of culture was used as an index of mitogenic activity. 
The cells were harvested onto filters and the radioactivity on the dried 
filters was measured in a 6 plate liquid scintillation counter (Pharmacia, 
Sweden). When the alloreacive T cell clone was used as the responder 
population, stimulation at a 1:l ratio was performed using COS cells 
transfected with cDNAs encoding the specific alloantigen (DR7) and 
either 87-l or 87-2. 
Repetltlve Stimulations 
CD4+CD45RA+ cells (5 x 10”) oer well were cultured in 96well flat- 
bottomed microtiter plates at 37’C in 5% CO,, with 2 x 10’ each of 
mitomycin-treated NIH 3T3 transfectants (DR7 transfectants, DR7/B7-1 
transfectants, DR7/B7-2 transfectants) in a primary allostimulation. 
Following 7 days of culture, alloreactive T cell populations were sepa- 
rated from the transfectants by percoll gradient as described (Boussi- 
otis et al., 1993a), rested in media overnight, and subsequently 5 x 
1 O’T cells were rechallenged with 2 x 1O’of each of the transfectants. 
Sequential (repetitive) stimulations were performed 5 times. Superna- 
tantS were harvested 46 hr after the primary stimulation and at 24 hr 
after each restimulation and assayed for IL-4 and IL-2 accumulation 
by ELISA. 
Alloantlgen-Speclflc T Cell Clones 
HlA-DR7 alloantigen-specific helper T cell clones were generated us- 
ing standard methodology (Goronzy et al., 1987). T cell clones were 
maintained by cycles of antigen stimulation and rest. Prior to use, Tcell 
clones were maintained for 10-15 days without antigenic stimulation. 
MLR 
For MLR responses, normal donor peripheral blood mononuclear cells 
were cultured with irradiated (2.5 Gy) normal donor peripheral blood 
mononuclear cells from HLA disparate individuals. Cells were cultured 
in RPM1 1640, 5% heat-inactivated human AB serum at 37“C in 5% 
CO2 at a final concentration of lOa cells/ml. Cells were cultured as 
indicated in theabsenceor presenceof anti-B7-1 MAb, anti-B7-2 MAb, 
CTLA4-Ig, or isotype control antibodies, all at a final concentration 
of 10 pa/ml. Cells were cultured in 25 cm* tissue culture flasks and 
harvested after 46 hr for RNA extraction. Proliferation was assessed 
in parallel experiments by measuring thymidine incorporation for the 
last 16 hr of a 5 day assay performed in g&well plates. 
Cytoklne Assays 
Cytokine concentrations in culture supernatants were assayed by 
ELlSAusingcommerciallyavailable kitsfor IL-2(BioSource, Camarillo, 
California), IL-4 (Endogen, Cambridge, Massachusetts), IFNy (Bio- 
Source, Camarillo, California), TNF8 (Boehringer Mannheim, India- 
napolis, Indiana). and GM-CSF (R & D Systems, Minneapolis, Minne- 
sota). Lymphokine levels were determined by comparison with a 
standard curve, which was linear down to the indicated lower limit of 
detection. 
lmmunofluorescence and Flow Cytometry 
T cells activated with anti-CD3 cross-linking alone, or in the presence 
of anti-CD3 and either CHO/B7-1 or CHO/B7-2 for 12, 24, and 48 hr 
were analyzed for the coexpression of IL-2Ra and IL-2Ry. Cells were 
stained with FlTC-conjugated anti-IL-2Ra and biotinylated anti-IL-2Ry 
MAbs or the appropriate controls (isotype-matched FITC-conjugated 
or biotinylated Mslg). Specific immunoreactivity of the biotinylated 
MAbs was determined using phycoerythrin-conjugated streptavidin as 
secondary reagent. 
RT-PCR 
CD4+ T cells were cultured at 1 x lo6 cells/well in 24well plates 
precoated with anti-CD3 MAb as described above, in the presence 
of CHOIBFl- or CHO/B7-2-transfected cells and harvested for RNA 
preparation after 6 hr (Chomczynski and Sacchi, 1987). RNA (2 pg) 
was used for reverse transcription as previously described (Boussiotis 
et al., 1994b). PCR amplification of cDNA from 2 pg of mRNA was 
performed using specific oligonucleotides for IL-2 or IL4 (Clontech, 
Palo Alto, California) for 34 cycles in a Perkin Elmer-Cetus thermal 
cycler (Cetus, Emoryville, California) in a 50 pl final volume as pre- 
viously described (Siebert and Larrick, 1993). A 20 sl aliquot of each 
of the final reaction products was electrophoresed on a 2.5% agarose 
gel containing ethidium bromide. 
RNA was prepared from an MLR reaction after 48 hr, the time deter- 
mined to be maximal for IL-2 and IL-4 mRNA expression. Levels of 
IL-2 and IL-4 mRNA were determined by competitive RT-PCR using 
a MIMIC template according to the instructions of the manufacturer 
(Siebert and Larrick, 1993; Clontech, Palo Alto, California). mRNA (1 
ug) was reverse transcribed and equal l/20 aliquots added to PCR 
reactions containing serial 19fold dilutions of PCR MIMICS comprised 
of the primer sequence for IL-2 or IL4 separated by a nonhomologous 
DNA. After PCR amplification, the products derived from the MIMIC 
template and cDNA were resolved on an agarose gel and the relative 
ethidium bromide staining intensities of the target and MIMIC DNAs 
compared. The PCR reaction was then repeated with a constant 
amount of cDNA and serial P-fold dilutions of the MIMIC covering 
the appropriate range and the DNA products were separated by gel 
electrophoresis. The amount of target cDNA was measured by de- 
termining how much MIMIC is required to produce equal molar quanti- 
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ties of both PCR products. The data was analysed for statistical signifi- 
cance using the paired Student’s t test. 
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